» Articles » PMID: 39292430

Research Participant Perceptions of Personal Utility in Disclosure of Individual Research Results from Genomic Analysis

Overview
Publisher Springer
Specialty Health Services
Date 2024 Sep 18
PMID 39292430
Authors
Affiliations
Soon will be listed here.
Abstract

This article elaborates research participant perspectives on the communication of individual research results from genomic analyses. While most analyses focus on how to communicate results from the perspectives of clinicians or researchers, there is insufficient data on user perspectives and how this information may be used, valued, and interpreted by patients and their families. The concept of personal utility, which considers factors related to quality of life, including on how information may impact the person's future decisions, has been shown to be particularly relevant to understand research participant perspectives and to move beyond clinical and analytic utility factors such as mortality and morbidity. This article draws from qualitative research of research participants awaiting genomic results in the case of sudden cardiac death. Our results show perspectives of personal utility in communication of genomic results, including cognitive, behavioral, and affective outcomes. Cognitive outcomes include gain of information, improved knowledge of etiology and inheritance characteristics, and curiosity for what might be found. Behavioral outcomes include being able to plan life decisions, while affective outcomes include various coping strategies used. We will also discuss the value of knowing negative results and incidental findings from the research participant's perspective. This contribution gives suggestions on best practices to guide genome analysis returns, including incorporating participant wishes on individualized communication at the consent stage; developing relational autonomy approaches; and engaging them throughout the research trajectory.

References
1.
Blasimme A, Brall C, Vayena E . Reporting Genetic Findings to Individual Research Participants: Guidelines From the Swiss Personalized Health Network. Front Genet. 2020; 11:585820. PMC: 7759560. DOI: 10.3389/fgene.2020.585820. View

2.
Fellmann F, van El C, Charron P, Michaud K, Howard H, Boers S . European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death. Eur J Hum Genet. 2019; 27(12):1763-1773. PMC: 6870982. DOI: 10.1038/s41431-019-0445-y. View

3.
Wright M, Lewis K, Fisher T, Hooker G, Emanuel T, Biesecker L . Preferences for results delivery from exome sequencing/genome sequencing. Genet Med. 2013; 16(6):442-7. PMC: 4597884. DOI: 10.1038/gim.2013.170. View

4.
Parker M, Lucassen A . Using a genetic test result in the care of family members: how does the duty of confidentiality apply?. Eur J Hum Genet. 2018; 26(7):955-959. PMC: 6018806. DOI: 10.1038/s41431-018-0138-y. View

5.
Pullman D, Hodgkinson K . Genetic knowledge and moral responsibility: ambiguity at the interface of genetic research and clinical practice. Clin Genet. 2006; 69(3):199-203. DOI: 10.1111/j.1399-0004.2006.00581.x. View